NEWS
03/18/2016 17:47 EDT | Updated 03/19/2017 01:12 EDT

Aurinia Pharmaceuticals posts loss of $4.1 million in 4th quarter

VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Friday reported a loss of $4.1 million in its fourth quarter.

On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 13 cents. Losses, adjusted for non-recurring gains, were 16 cents per share.

The biotechnology company posted revenue of $57,000 in the period.

For the year, the company reported that its loss widened to $18.6 million, or 58 cents per share. Revenue was reported as $235,000.

In the final minutes of trading on Friday, the company's shares hit $3.04. A year ago, they were trading at $4.80.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at http://www.zacks.com/ap/AUPH

_____

Keywords: Aurinia Pharmaceuticals, Earnings Report

The Associated Press